Name: 글로벌 시장 동향
SKU: DMBT2364
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 합성생물학 시장 규모는 2022년 XX백만 달러였으며, 2030년까지 XX백만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 XX%입니다.
합성생물학은 생물학에 공학 원리를 적용하는 새로운 융합 학문 분야입니다. 합성생물학은 (재)설계 및 제작을 통해 자연계에 존재하지 않는 생물 시스템과 구성 요소를 만들어내는 것을 목표로 합니다. 합성생물학을 활용하면 연구자들은 분류된 DNA 서열을 신속하게 생산하고 이를 조립하여 새로운 게놈을 만들 수 있습니다. 합성생물학은 DNA의 화학적 합성과 확장되는 유전체학 지식을 결합한 학문입니다. DNA 합성 속도와 비용의 발전으로 과학자들은 이제 개선된 바이오연료, 바이오제품, 재생 가능한 화학물질, 바이오 기반 특수 화학물질 제조는 물론 의료 산업에도 활용될 수 있는 변형된 박테리아 염색체를 만들 수 있게 되었습니다.

시장 동향
글로벌 합성생물학 시장을 이끄는 주요 요인은 주요 기업들의 전략적 투자로 인한 시장 성장 촉진, 진단 및 기술 개선 지원 등입니다. 단백질 치료제, 맞춤형 의학, 합성 의약품 및 백신 연구에 대한 수요 증가가 시장 성장을 견인할 것으로 예상됩니다.
주요 기업들의 전략적 투자는 시장 성장을 촉진할 것으로 전망됩니다.
제약 회사들은 신약 개발을 위한 연구 개발에 더 많은 자금을 투자하고 있습니다. 다양한 제약 및 생명공학 기업에 대한 정부 지원 프로그램은 건강 보조 식품 및 명상 연구를 장려해 왔습니다.
합성생물학에 대한 사회적 인식이 변화함에 따라 합성생물학 제품 시장은 성장하고 있습니다. 결과적으로 주요 시장 참여 기업들은 기업 성장과 수요 충족을 위해 인수, 협력 등의 전략적 개발에 투자하고 있습니다. 예를 들어, 합성생물학 분야의 선두 스타트업인 코덱시스(Codexis, Inc.)와 유명 생명과학 투자사인 캐스딘 캐피털(Casdin Capital)은 2020년 11월 합성생물학 혁신 액셀러레이터(SynBio Innovation Accelerator)를 설립했습니다. 일본의 주요 기업 중 하나인 스미토모 화학(Sumitomo Chemical)은 합성생물학 기반의 차세대 사업 개발을 촉진하기 위해 미국에 신생 기업인 신바이오 허브(SynBio Hub)를 설립했습니다.
2020년 합성생물학 산업 스타트업에 대한 투자는 총 78억 달러에 달했고, 2021년에는 180억 달러에 이르렀습니다. DNA 스크립트(DNA Script)와 아버 바이오테크놀로지스(Arbor Biotechnologies)는 각각 약 2억 1,500만 달러와 1억 6,720만 달러의 투자를 유치했습니다. 이러한 상당한 규모의 투자는 시장에 자금 흐름을 촉진하고 공급망을 따라 사업 확장을 지원합니다.
하지만 안전성 문제로 인해 시장 확장이 저해될 가능성도 있습니다.

그러나 유전자 변형 생물체가 의도적이든 비의도적이든 환경에 방출될 경우 사람과 생태계 모두의 건강에 악영향을 미칠 수 있습니다. 결과적으로 이는 시장 확장을 저해할 것으로 예상됩니다.
COVID-19 영향 분석
지난 2년간 COVID-19 발생으로 인해 합성 생물학 제품의 사용이 확대되었습니다. COVID-19 진단 키트, 치료제, 백신 개발을 위한 새로운 방법을 활용하면서 많은 주요 제약 및 생명공학 기업과 합성 생물학 산업 참여자들이 전 세계적으로 연구 활동을 강화했습니다. 유럽 의회의 연구에 따르면 합성 생물학은 떠오르는 기술 중 하나이며, COVID-19 감염 퇴치에 적용될 수 있습니다. 미국 국립보건원(NIH) 또한 백신 개발을 가속화하기 위한 합성 생물학의 활용을 강조했습니다.
합성 생물학은 기초적인 학문적 연구에서 벗어나 견고하고 부분적으로 산업화된 전략으로 발전했습니다. 코로나19 팬데믹 기간 동안 합성생물학이 제공하는 생의학적 기회는 그 어느 때보다 분명하게 드러났습니다. 연구 발전부터 백신, 치료제, 진단법의 신속한 개발에 이르기까지, 이 분야는 전 세계적인 재난 상황에서 큰 공헌을 했습니다. DNA 및 RNA 합성 등 다양한 합성생물학 공정의 자동화는 이 중요한 분야의 발전에 필수적이었습니다. 합성생물학의 성장세를 바탕으로 감염성 질환을 넘어 암, 대사 질환, 유전 질환 등 다양한 분야로 그 이점을 확장하기 위해서는 기업들이 현재의 자동화 플랫폼을 개선하고 여전히 수작업으로 진행되는 단계들을 자동화하는 데 더욱 박차를 가해야 할 것입니다.
세그먼트 분석
헬스케어 부문은 예측 기간(2023-2030년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
응용 부문은 전 세계 합성생물학 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 합성생물학의 빠른 발전은 설계된 파지, 인공 세포, 살아있는 박테리아를 활용한 다양한 치료 기술 측면에서 헬스케어 부문의 성장을 견인했습니다.

예를 들어, 합성생물학은 생명공학 기술 분야에서 높은 발현율, 빠른 결과, 그리고 높은 용량을 지닌 항원과 변이체를 만들어내는 것을 가능하게 했습니다. 합성생물학의 응용 분야는 의약품 및 백신 개발부터 제품 생산 및 진단 절차에 이르기까지 다양합니다.
연구자들은 합리적인 엔지니어링 방법을 사용하여 프로세서, 센서, 그리고 리포터로 구성된 독창적이고 동적인 바이오센싱 시스템을 개발합니다. 다발성 경화증과 같은 신경계 질환의 증가 또한 이 시장의 성장을 촉진하고 있습니다. 예를 들어, 2022년 7월부터 토론토 공과대학의 합성생물학 전문가들은 환자 조직에서 맞춤형 줄기세포를 만들어 질병을 치료하는 연구를 진행하고 있습니다. 이러한 연구 활동은 해당 부문의 성장을 뒷받침할 것으로 예상됩니다. 또한, 정부 및 기타 기관에서 수행하는 여러 연구 프로젝트들도 이 분야의 연구 발전에 기여할 것으로 기대됩니다.
지역 분석
북미는 전 세계 합성생물학 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 인구 규모, 우수한 의료 인프라, 그리고 높은 소득 수준을 바탕으로 전 세계 합성생물학 시장을 주도하고 있습니다. 바이오 기반 제품에 대한 수요 증가, 합성 생물학 사업에 대한 투자 증가, 그리고 합성 생물학 연구 개발 자금 지원 확대에 힘입어 북미는 전 세계 합성 생물학 시장에서 가장 큰 비중을 차지할 것으로 예상됩니다. 이는 정부 지원 확대, 유리한 법률 환경, 그리고 합성 생물학 제품 개발에 대한 투자 증가에 따른 결과입니다. 2020년 상반기에 모더나 테라퓨틱스, 사나 바이오테크놀로지스, 포세이다 테라퓨틱스, 에이필 사이언스, 그린라이트 바이오사이언스를 포함한 이 업계 기업들은 30억 달러 이상의 자금을 조달했습니다.
미국에서는 단백질체학, 유전체 구조 예측, 신약 개발 연구가 높은 가치를 인정받고 있으며, 이는 합성 생물학 분야에 긍정적인 영향을 미치고 있습니다. 또한, 빌 게이츠 재단과 멜린다 재단과 같은 영리 기업과 국립보건원(NIH)과 같은 정부 지원 연구 기관들이 합성 생물학 연구 개발을 장려하고 있어 국가 경제 발전에 기여할 가능성이 높습니다. 또한, 공공 및 민간 기관의 자금 지원 증가와 신약 개발을 위한 연구 개발 지출 증가는 예측 기간 동안 시장 성장을 견인할 것으로 예상되는 중요한 성장 요인입니다.
경쟁 환경
합성 생물학 시장은 Amyris Inc., Algenol Biofuels Inc., Bayer AG, CBC Comprehensive Biomarker Center GmbH, Bristol-Myers Squibb, Biosearch Technologies Inc., Gene Script Corporation, GeneWorks Pty Ltd., DuPont Inc., Thermo Fisher Scientific Inc. 등 국내외 기업들이 경쟁하는 비교적 경쟁적인 시장입니다. 주요 기업들은 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 채택하여 시장 성장에 기여하고 있습니다. 예를 들어, 2021년 7월 Codexis, Inc.와 Kalsec, Inc.는 연구 파트너십 확대를 발표하는 것 외에도 Kalsec의 새로운 천연 홉산 생산에 사용될 새로운 효소에 대한 독점 공급 계약을 체결했습니다.

써모 피셔 사이언티픽(Thermo Fisher Scientific Inc.)
개요: 써모 피셔 사이언티픽(Thermo Fisher Scientific Inc.)은 연구, 진단 및 임상 실험실에서 요구되는 까다로운 분석 문제를 해결하기 위해 의료 장비, 분석 기기, 시약 및 소모품, 소프트웨어 및 서비스를 제공합니다. 유세포 분석, 합성 생물학 및 세포 생물학 분야에 대한 솔루션을 제공하며, 단백질 및 분자 생물학 연구, 전자 현미경, 질량 분석 및 유전자 시퀀싱 기술을 비롯한 다양한 제품을 제공합니다. 이 회사는 학술 및 연구 기관, 정부 기관, 제약 및 생명 공학 회사, 임상 진단 실험실, 환경, 산업 품질 및 공정 제어 분야에 서비스를 제공합니다.
제품 포트폴리오:
인비트로젠 진아트(Invitrogen GeneArt) 유전자 합성 서비스: 진아트 맞춤형 유전자 합성을 통해 100% 서열 정확도를 가진 고유한 DNA 구조를 쉽고 경제적으로 얻을 수 있습니다. 이 회사는 특허받은 진옵티마이저(GeneOptimizer) 알고리즘을 사용하여 최적화를 제공하며, 이 알고리즘은 코돈 최적화를 넘어선 특수 다인자 전략을 통해 합성 유전자의 발현을 극대화합니다.

글로벌 합성생물학 시장 보고서는 약 45개 이상의 시장 데이터 표, 40개 이상의 그림 및 200페이지(약) 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global synthetic biology market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).
The application of engineering principles to biology is the focus of the emerging interdisciplinary field of synthetic biology. It aspires to create biological systems and parts that do not already exist in the natural world through (re-)design and fabrication. With the help of synthetic biology, researchers can quickly produce cataloged DNA sequences and assemble them into new genomes. Synthetic biology combines the chemical synthesis of DNA with expanding genomics knowledge. Scientists are now able to create modified bacterial chromosomes that can be employed in manufacturing improved biofuels, bioproducts, renewable chemicals, and bio-based specialty chemicals, as well as in the healthcare industry, due to advancements in the speed and cost of DNA synthesis.
Market Dynamics
The major factors driving the global synthetic biology market the key companies are anticipated to make strategic investments to drive the market, improved diagnosis and techniques to support. The market is anticipated to rise in response to the rising demand for protein therapies, individualized medicine, and research into synthetic drugs and vaccines.
Key companies are anticipated to make strategic investments is expected to drive the market’s growth.
More funding is now being allocated to pharmaceutical companies for research and development to find new medications. Government programs subsidizing various pharma and biotech companies have promoted research into dietary supplements and meditation.
The market for synthetic biology products rises as societal perceptions of synthetic biology change. As a result, major market players invest in strategic development through activities like acquisition, collaboration, etc., to grow their companies and meet demand. For instance, the SynBio Innovation Accelerator was introduced by premier synthetic biology start-up Codexis, Inc. and a renowned life science investor, Casdin Capital, in November 2020. One of the major players in Japan, Sumitomo Chemical, established SynBio Hub, a new company in the U.S., intending to foster the development of synthetic biology-based next-generation businesses.
In 2020, investments in start-ups in the synthetic biology industry totalled $7.8 billion, and in 2021, they reached $18.0 billion. Companies like DNA Script and Arbor Biotechnologies raised about 215 million and 167.2 million dollars, respectively. The significant investment promotes the flow of money through the market and aids in the expansion of businesses along the supply chain.
The market's expansion will likely be hampered by safety concerns.
However, the intentional or unintentional release of genetically modified organisms into the environment could have detrimental effects on the health of both people and the ecosystem. In consequence, it is anticipated that this will impede market expansion.
COVID-19 Impact Analysis
The use of synthetic biology products has expanded during the last two years due to the COVID-19 outbreak. By using novel methods for creating test kits, treatments, and vaccinations for COVID-19, many major pharmaceutical and bioTechnologies businesses and synthetic biology industry participants have intensified their research operations globally. Synthetic biology is one of the emerging technologies, according to a study from the European Parliament. It can be applied to the fight against COVID-19 infection. The National Institute of Health in the U.S. has also highlighted the use of synthetic biology to hasten the creation of vaccines.
Synthetic biology has evolved from a rudimentary academic endeavor to a solid, partially industrialized strategy. During the COVID-19 pandemic, the biomedical opportunities provided by synthetic biology have never been more apparent: from advancing research to enabling quicker development of vaccines, therapeutics, and diagnostics, this discipline has made great contributions during a worldwide catastrophe. Automating the many synthetic biology processes, such as DNA and RNA synthesis, has been crucial to developing this significant field. Building on the momentum of synthetic biology and extending its advantages to areas beyond infectious diseases, such as cancer, metabolic, and genetic disorders, companies would need to improve the present automation platforms and carry on with the automation of stages that are still done manually.
Segment Analysis
The healthcare segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)
The application segment is the highest market holder in the global synthetic biology market. The quick advancement of synthetic biology has driven the healthcare segment in terms of the various treatment techniques utilizing designed phages, artificial cells, and live bacteria.
For instance, it has made it possible for life technologies to create antigens and variants with high expression, quick outcomes, and capacity. Applications for synthetic biology range from the creation of drugs and vaccines to the production of products and diagnostic procedures.
Researchers use rational engineering methods to create unique, dynamic biosensing systems composed of a processor, sensor, and reporter. A growth in neurological diseases like multiple sclerosis is also fueling this market. For instance, starting in July 2022, synthetic biology specialists at the University of Toronto Engineering are creating personalized stem cells from patient tissues to treat ailments. These research initiatives are expected to support segment growth. Additionally, several initiatives performed by governments and other organizations are anticipated to benefit the market for research in this segment.
Geographical Analysis
North America holds the largest market share in the global synthetic biology market.
North America dominates the global Synthetic Biology market primarily due to its large population, excellent medical infrastructure, and high-income levels. Due to the expanding demand for bio-based products, rising investments in synthetic biology businesses, and rising R&D funding for synthetic biology, North America is predicted to have the greatest proportion of the global market for synthetic biology. as a result of greater government support, favorable laws, and increased investment in the development of synthetic biological products. In the first half of 2020, businesses in this industry, including Moderna Therapeutics, Sana BioTechnologies, Poseida Therapeutics, Apeel Sciences, and Greenlight Biosciences, raised more than $3 billion in financing.
Proteomics, genomic structure prediction, and drug development research are highly valued in the U.S., which is good for the synthetic biology sector. Additionally, certain for-profit businesses like the Gates and Melinda Foundation and government-funded research institutions like the National Institutes of Health (NIH) are promoting synthetic biology research and development, which could improve the chances for the nation's economic development. Additionally, growing funding from public and private organizations and R&D expenditures on drug development are significant growth factors anticipated to propel the market throughout the forecast period.
Competitive Landscape
The Synthetic Biology market is moderately competitive with local and global companies’ presence Amyris Inc., Algenol Biofuels Inc., Bayer AG, CBC Comprehensive Biomarker Center GmbH, Bristol-Myers Squibb, Biosearch Technologies Inc., Gene Script Corporation, GeneWorks Pty Ltd., DuPont Inc., Thermo Fisher Scientific In and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in July 2021, addition to announcing the expansion of their research partnership, Codexis, Inc. and Kalsec, Inc. also signed a unique supply arrangement for a novel enzyme that will be used to create Kalsec's newest natural hop acid.
Thermo Fisher Scientific Inc.
Overview: In order to meet the demands of difficult analytical problems in research, diagnostics, and clinical laboratories, Thermo Fisher Scientific Inc. (Thermo Fisher) offers medical equipment, analytical instruments, reagents and consumables, software, and services. It provides answers for flow cytometry, synthetic biology, and cellular biology. The company offers a variety of goods, including as technologies for protein and molecular biology research, electron microscopy, mass spectrometry, and genetic sequencing. The business provides services to academic and research institutions, government agencies, pharmaceutical and biotech firms, clinical diagnostic laboratories, environmental, industrial quality, and process control sectors.
Product Portfolio:
Invitrogen GeneArt Gene Synthesis Services: Getting unique DNA constructions with 100% sequence fidelity is easy and affordable with GeneArt Custom Gene Synthesis. The company offers optimization using the patented GeneOptimizer algorithm, which uses a special multifactorial strategy that goes beyond codon optimization, to maximize the expression of synthetic genes.
The global Synthetic Biology market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Key companies are anticipated to make strategic investments to drive the market.
4.1.1.2. Improved diagnosis and techniques to support.
4.1.2. Restraints:
4.1.2.1. The market's expansion will likely be hampered by safety concerns.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1 Porter's Five Forces Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
5.4 Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Core Product
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.2.2.1. Synthetic Genes
7.2.2.2. Synthetic DNA
7.2.2.3. Synthetic Cells
7.2.2.4. Chassis Organisms
7.2.2.5. Others
7.3. Enabling Product
7.3.1.1. Oligonucleotide Synthesis
7.3.1.2. DNA Synthesis
8. By Technologies
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
8.1.2. Market Attractiveness Index, By Technologies
8.2. Gene Synthesis
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Genome Engineering
8.4. Sequencing
8.5. Bioinformatics
8.6. Cloning
8.7. Site-Directed Mutagenesis
8.8. Measurement & Modeling
8.9. Microfluidics
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Healthcare
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Food & Agriculture
9.4. Chemicals
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Products Benchmarking
11.4. List of Key Companies to Watch
12. Company Profiles
12.1. Amyris Inc
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Algenol Biofuels Inc.
12.3. Bayer AG
12.4. CBC Comprehensive Biomarker Center GmbH
12.5. Bristol-Myers Squibb
12.6. Biosearch Technologies Inc.
12.7. Gene Script Corporation
12.8. GeneWorks Pty Ltd.
12.9. DuPont Inc.
12.10. Thermo Fisher Scientific In.
LIST NOT EXHAUSTIVE
13. Global Synthetic Biology Market – DataM
13.1. Appendix
13.2. About Us and Application
13.3. Contact Us

언급된 주요 기업들

Amyris Inc, Algenol Biofuels Inc., Bayer AG, CBC Comprehensive Biomarker Center GmbH, Bristol-Myers Squibb, Biosearch Technologies Inc., Gene Script Corporation, GeneWorks Pty Ltd., DuPont Inc., Thermo Fisher Scientific In.

표 목록 (Tables)

List of Tables Table 1 Global Synthetic Biology Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Synthetic Biology Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Synthetic Biology Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Synthetic Biology Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Synthetic Biology Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Synthetic Biology Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Synthetic Biology Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 8 Global Synthetic Biology Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Synthetic Biology Market Value, By Technology, 2022-2033 (US$ Billion)

Table 10 Global Synthetic Biology Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 11 Global Synthetic Biology Market Value, By Application, 2022-2033 (US$ Billion)

Table 12 Global Synthetic Biology Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 13 Global Synthetic Biology Market Value, By End-User, 2022-2033 (US$ Billion)

Table 14 Global Synthetic Biology Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 15 Global Synthetic Biology Market Value, By Region, 2022-2033 (US$ Billion)

Table 16 North America Synthetic Biology Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 17 North America Synthetic Biology Market Value, By Technology, 2022-2033 (US$ Billion)

Table 18 North America Synthetic Biology Market Value, By Application, 2022-2033 (US$ Billion)

Table 19 North America Synthetic Biology Market Value, By End-User, 2022-2033 (US$ Billion)

Table 20 North America Synthetic Biology Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Europe Synthetic Biology Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 22 Europe Synthetic Biology Market Value, By Technology, 2022-2033 (US$ Billion)

Table 23 Europe Synthetic Biology Market Value, By Application, 2022-2033 (US$ Billion)

Table 24 Europe Synthetic Biology Market Value, By End-User, 2022-2033 (US$ Billion)

Table 25 Europe Synthetic Biology Market Value, By Country, 2022-2033 (US$ Billion)

Table 26 Asia-Pacific Synthetic Biology Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 27 Asia-Pacific Synthetic Biology Market Value, By Technology, 2022-2033 (US$ Billion)

Table 28 Asia-Pacific Synthetic Biology Market Value, By Application, 2022-2033 (US$ Billion)

Table 29 Asia-Pacific Synthetic Biology Market Value, By End-User, 2022-2033 (US$ Billion)

Table 30 Asia-Pacific Synthetic Biology Market Value, By Country, 2022-2033 (US$ Billion)

Table 31 South America Synthetic Biology Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 32 South America Synthetic Biology Market Value, By Technology, 2022-2033 (US$ Billion)

Table 33 South America Synthetic Biology Market Value, By Application, 2022-2033 (US$ Billion)

Table 34 South America Synthetic Biology Market Value, By End-User, 2022-2033 (US$ Billion)

Table 35 South America Synthetic Biology Market Value, By Country, 2022-2033 (US$ Billion)

Table 36 Middle East and Africa Synthetic Biology Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 37 Middle East and Africa Synthetic Biology Market Value, By Technology, 2022-2033 (US$ Billion)

Table 38 Middle East and Africa Synthetic Biology Market Value, By Application, 2022-2033 (US$ Billion)

Table 39 Middle East and Africa Synthetic Biology Market Value, By End-User, 2022-2033 (US$ Billion)

Table 40 Middle East and Africa Synthetic Biology Market Value, By Country, 2022-2033 (US$ Billion)

Table 41 Illumina, Inc.: Overview

Table 42 Illumina, Inc.: Product Portfolio

Table 43 Illumina, Inc.: Key Developments

Table 44 Merck KGaA: Overview

Table 45 Merck KGaA: Product Portfolio

Table 46 Merck KGaA: Key Developments

Table 47 Thermo Fisher Scientific Inc.: Overview

Table 48 Thermo Fisher Scientific Inc.: Product Portfolio

Table 49 Thermo Fisher Scientific Inc.: Key Developments

Table 50 Bota Biosciences: Overview

Table 51 Bota Biosciences: Product Portfolio

Table 52 Bota Biosciences: Key Developments

Table 53 Codexis, Inc.: Overview

Table 54 Codexis, Inc.: Product Portfolio

Table 55 Codexis, Inc.: Key Developments

Table 56 Twist Bioscience: Overview

Table 57 Twist Bioscience: Product Portfolio

Table 58 Twist Bioscience: Key Developments

Table 59 Creative Biogene: Overview

Table 60 Creative Biogene: Product Portfolio

Table 61 Creative Biogene: Key Developments

Table 62 Eurofins Genomics: Overview

Table 63 Eurofins Genomics: Product Portfolio

Table 64 Eurofins Genomics: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Synthetic Biology Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Synthetic Biology Market Share, By Technology, 2024 & 2033 (%)

Figure 4 Global Synthetic Biology Market Share, By Application, 2024 & 2033 (%)

Figure 5 Global Synthetic Biology Market Share, By End-User, 2024 & 2033 (%)

Figure 6 Global Synthetic Biology Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Synthetic Biology Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 8 Oligonucleotides and Synthetic DNA Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 9 Enzymes Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 10 Cloning Technologies Kits Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 11 Synthetic Cells Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 12 Xeno-Nucleic Acids Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 13 Chassis Organism Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 14 Others Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 15 Global Synthetic Biology Market Y-o-Y Growth, By Technology, 2023-2033 (%)

Figure 16 Genome Engineering Technology in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 17 Sequencing Technology in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 18 Bioinformatics Technology in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 19 Cloning Technology in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 20 Nanotechnology Technology in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 21 Others Technology in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 22 Global Synthetic Biology Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 23 Medical Applications Application in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 24 Industrial Applications Application in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 25 Food and Animal Health Applications Application in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 26 Agricultural Applications Application in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 27 Environmental Applications Application in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 28 Others Application in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 29 Global Synthetic Biology Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 30 Pharmaceutical & Biotechnology Companies End-User in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 31 Industrial & Chemical Companies End-User in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 32 Food & Beverage Companies End-User in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 33 Academic and Research Institutes End-User in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 34 Others End-User in Global Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 35 Global Synthetic Biology Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 36 North America Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 37 North America Synthetic Biology Market Share, By Product Type, 2024 & 2033 (%)

Figure 38 North America Synthetic Biology Market Share, By Technology, 2024 & 2033 (%)

Figure 39 North America Synthetic Biology Market Share, By Application, 2024 & 2033 (%)

Figure 40 North America Synthetic Biology Market Share, By End-User, 2024 & 2033 (%)

Figure 41 North America Synthetic Biology Market Share, By Country, 2024 & 2033 (%)

Figure 42 Europe Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 43 Europe Synthetic Biology Market Share, By Product Type, 2024 & 2033 (%)

Figure 44 Europe Synthetic Biology Market Share, By Technology, 2024 & 2033 (%)

Figure 45 Europe Synthetic Biology Market Share, By Application, 2024 & 2033 (%)

Figure 46 Europe Synthetic Biology Market Share, By End-User, 2024 & 2033 (%)

Figure 47 Europe Synthetic Biology Market Share, By Country, 2024 & 2033 (%)

Figure 48 Asia-Pacific Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 49 Asia-Pacific Synthetic Biology Market Share, By Product Type, 2024 & 2033 (%)

Figure 50 Asia-Pacific Synthetic Biology Market Share, By Technology, 2024 & 2033 (%)

Figure 51 Asia-Pacific Synthetic Biology Market Share, By Application, 2024 & 2033 (%)

Figure 52 Asia-Pacific Synthetic Biology Market Share, By End-User, 2024 & 2033 (%)

Figure 53 Asia-Pacific Synthetic Biology Market Share, By Country, 2024 & 2033 (%)

Figure 54 South America Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 55 South America Synthetic Biology Market Share, By Product Type, 2024 & 2033 (%)

Figure 56 South America Synthetic Biology Market Share, By Technology, 2024 & 2033 (%)

Figure 57 South America Synthetic Biology Market Share, By Application, 2024 & 2033 (%)

Figure 58 South America Synthetic Biology Market Share, By End-User, 2024 & 2033 (%)

Figure 59 South America Synthetic Biology Market Share, By Country, 2024 & 2033 (%)

Figure 60 Middle East and Africa Synthetic Biology Market Value, 2022-2033 (US$ Billion)

Figure 61 Middle East and Africa Synthetic Biology Market Share, By Product Type, 2024 & 2033 (%)

Figure 62 Middle East and Africa Synthetic Biology Market Share, By Technology, 2024 & 2033 (%)

Figure 63 Middle East and Africa Synthetic Biology Market Share, By Application, 2024 & 2033 (%)

Figure 64 Middle East and Africa Synthetic Biology Market Share, By End-User, 2024 & 2033 (%)

Figure 65 Illumina, Inc.: Financials

Figure 66 Merck KGaA: Financials

Figure 67 Thermo Fisher Scientific Inc.: Financials

Figure 68 Bota Biosciences: Financials

Figure 69 Codexis, Inc.: Financials

Figure 70 Twist Bioscience: Financials

Figure 71 Creative Biogene: Financials

Figure 72 Eurofins Genomics: Financials

글로벌 합성생물학 시장 – 2023-2030

Global Synthetic Biology Market - 2023-2030